Does Abacavir Lamivudine And Zidovudine Interact with Doxorubicin?
CDI records a contraindicated classification for Abacavir Lamivudine And Zidovudine and Doxorubicin. The stored summary is: Concomitant use with zidovudine should be avoided due to demonstrated in vitro antagonistic relationship. The mechanism involves antagonistic relationship demonstrated in vitro. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Contraindicated
- Abacavir Lamivudine And Zidovudine Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Management
- Do not take together
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Antagonistic relationship demonstrated in vitro
What To Tell Your Doctor or Pharmacist
If you are taking Abacavir Lamivudine And Zidovudine and your doctor is considering prescribing Doxorubicin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask about alternative medications that do not interact with your current regimen
- Ask how frequently you should be monitored while these are co-prescribed
- Never stop or change either medication without first consulting your healthcare provider